These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Application of Hepatocyte Growth Factor for Amyotrophic Lateral Sclerosis]. Aoki M; Warita H; Kato M; Suzuki N Brain Nerve; 2019 Nov; 71(11):1253-1260. PubMed ID: 31722311 [TBL] [Abstract][Full Text] [Related]
7. Intrathecal delivery of hepatocyte growth factor from amyotrophic lateral sclerosis onset suppresses disease progression in rat amyotrophic lateral sclerosis model. Ishigaki A; Aoki M; Nagai M; Warita H; Kato S; Kato M; Nakamura T; Funakoshi H; Itoyama Y J Neuropathol Exp Neurol; 2007 Nov; 66(11):1037-44. PubMed ID: 17984685 [TBL] [Abstract][Full Text] [Related]
8. [Clinical translation of hepatocyte growth factor for amyotrophic lateral sclerosis]. Warita H; Kato M; Suzuki N; Itoyama Y; Aoki M Rinsho Shinkeigaku; 2012; 52(11):1214-7. PubMed ID: 23196568 [TBL] [Abstract][Full Text] [Related]
9. [Amyotrophic lateral sclerosis: recent insights from transgenic animal models with SOD1 mutations]. Aoki M Rinsho Shinkeigaku; 2004 Nov; 44(11):788-91. PubMed ID: 15651292 [TBL] [Abstract][Full Text] [Related]
10. Rats expressing human cytosolic copper-zinc superoxide dismutase transgenes with amyotrophic lateral sclerosis: associated mutations develop motor neuron disease. Nagai M; Aoki M; Miyoshi I; Kato M; Pasinelli P; Kasai N; Brown RH; Itoyama Y J Neurosci; 2001 Dec; 21(23):9246-54. PubMed ID: 11717358 [TBL] [Abstract][Full Text] [Related]
11. Development of a rat model of amyotrophic lateral sclerosis expressing a human SOD1 transgene. Aoki M; Kato S; Nagai M; Itoyama Y Neuropathology; 2005 Dec; 25(4):365-70. PubMed ID: 16382787 [TBL] [Abstract][Full Text] [Related]
12. Delayed disease onset and extended survival in the SOD1G93A rat model of amyotrophic lateral sclerosis after suppression of mutant SOD1 in the motor cortex. Thomsen GM; Gowing G; Latter J; Chen M; Vit JP; Staggenborg K; Avalos P; Alkaslasi M; Ferraiuolo L; Likhite S; Kaspar BK; Svendsen CN J Neurosci; 2014 Nov; 34(47):15587-600. PubMed ID: 25411487 [TBL] [Abstract][Full Text] [Related]
13. Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation. Peviani M; Salvaneschi E; Bontempi L; Petese A; Manzo A; Rossi D; Salmona M; Collina S; Bigini P; Curti D Neurobiol Dis; 2014 Feb; 62():218-32. PubMed ID: 24141020 [TBL] [Abstract][Full Text] [Related]
14. Aberrant localization of FUS and TDP43 is associated with misfolding of SOD1 in amyotrophic lateral sclerosis. Pokrishevsky E; Grad LI; Yousefi M; Wang J; Mackenzie IR; Cashman NR PLoS One; 2012; 7(4):e35050. PubMed ID: 22493728 [TBL] [Abstract][Full Text] [Related]
15. Intrathecal delivery of recombinant AAV1 encoding hepatocyte growth factor improves motor functions and protects neuromuscular system in the nerve crush and SOD1-G93A transgenic mouse models. Lee SH; Kim S; Lee N; Lee J; Yu SS; Kim JH; Kim S Acta Neuropathol Commun; 2019 Jun; 7(1):96. PubMed ID: 31189468 [TBL] [Abstract][Full Text] [Related]
16. Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS). Van Dyke JM; Smit-Oistad IM; Macrander C; Krakora D; Meyer MG; Suzuki M Exp Neurol; 2016 Mar; 277():275-282. PubMed ID: 26775178 [TBL] [Abstract][Full Text] [Related]
18. [Clinical genetics of amyotrophic lateral sclerosis in Japan: an update]. Aoki M; Warita H; Suzuki N; Kato M Rinsho Shinkeigaku; 2012; 52(11):844-7. PubMed ID: 23196439 [TBL] [Abstract][Full Text] [Related]
19. Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis. Jiang HQ; Ren M; Jiang HZ; Wang J; Zhang J; Yin X; Wang SY; Qi Y; Wang XD; Feng HL Neuroscience; 2014 Sep; 277():132-8. PubMed ID: 24699224 [TBL] [Abstract][Full Text] [Related]
20. Bromocriptine methylate suppresses glial inflammation and moderates disease progression in a mouse model of amyotrophic lateral sclerosis. Tanaka K; Kanno T; Yanagisawa Y; Yasutake K; Hadano S; Yoshii F; Ikeda JE Exp Neurol; 2011 Nov; 232(1):41-52. PubMed ID: 21867702 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]